RedHill Biopharma reports positive opaganib data in venetoclax-resistant CLL

Vanda files FDA Biologics License Application for imsidolimab in generalized pustular psoriasis

Amferia raises EUR3.5m to advance antimicrobial wound-care platform

Sobi s Aspaveli marketing authorisation receives positive European regulatory opinion

Sobi agrees to acquire Arthrosi Therapeutics

Anixa Biosciences reveals final data from Phase one clinical trial of investigational breast cancer vaccine at 2025 San Antonio Breast Cancer Symposium

Amgen's UPLIZNA receives US FDA approval

Innovent Biologics' mazdutide injection meets Phase 1b clinical study primary endpoint

FDA grants priority review to Bristol Myers Squibb's Opdivo regimen for advanced Hodgkin lymphoma

Physiomics secures new contract with Numab Therapeutics for preclinical antibody development

OTR Therapeutics agrees strategic collaboration and licence agreement with Zealand Pharma A/S

Privo Technologies doses first patient in first-in-human clinical trial of PRV131

Senhwa Biosciences signs clinical supply agreement with BeOne Medicines

InduPro secures strategic investment and collaboration with Sanofi to advance autoimmune therapy

Innovent Biologics reports first participant dosed in Phase 1 trial of IBI3011